Everdrone announces new board of directors to drive expansion

February 19, 2026
Everdrone

Everdrone, a provider of autonomous drone systems for use in healthcare and emergency response, has appointed a new board of …

Indegene completes acquisition of Cake Health

February 18, 2026
Cake Health, Indegene

Indegene, a life sciences solutions company, has announced its acquisition of Cake Health, a healthcare agency, as well as its …

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026
Manufacturing and Production Gedeon Richter UK, Neurology

Gedeon Richter UK has announced its acquisition of full marketing and distribution rights to Reagila (cariprazine), a schizophrenia treatment, from …

ENA Respiratory doses first patients with INNA-051 antiviral nasal spray

February 17, 2026
Ear Nose & throat, Ena Respiratory

ENA Respiratory, a clinical-stage biopharmaceutical company specialising in the prevention of viral respiratory infections, has announced the first dosing of …

New medtech company Carvolix created as Affluent Medical acquires Caranx Medical and Artedrone

February 16, 2026
Research and Development Cardiology, Carvolix

Carvolix (formerly Affluent Medical), a commercial and clinical-stage biotechnology company developing AI-powered mini-robots and biomimetic implants, has completed the acquisition …

Qlaris Bio appoints Robert Warner to board of directors

February 16, 2026
Qlaris Bio

Qlaris Bio has appointed Robert Warner to its board of directors. Warner brings significant experience in life sciences leadership to …

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026
Research and Development Cardiology, Rhythm AI, atrial fibrillation

Rhythm AI, a UK-based company specialising in atrial fibrillation procedures, has announced that its STAR Apollo Mapping System has received …

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026
Manufacturing and Production iOrganBio

iOrganBio has announced the appointment of Karol Jarzabek as Chief Operating Officer (COO). Jarzabek specialises in operational management and business …

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026
Business Services, Consultancy Ensera Design

Ensera Design, a healthcare product innovation consultancy, has announced the expansion of its UK leadership team with multiple new appointments. …

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026
Research and Development Infinitopes, Oncology

Infinitopes, a clinical stage biotechnology company specialising in oncology, has announced the receipt of an additional $15.4m in seed funding, …

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026
Angelini Pharma

Angelini Pharma, the pharmaceutical branch of Angelini Industries, has announced the appointment of Roberto Scrivo as Chief of External Affairs, …

Hongene Biotech receives Gates Foundation grant to drive mRNA vaccine production

February 10, 2026
Manufacturing and Production Hongene Biotech, mRNA vaccine

Hongene Biotech, a contract development and manufacturing organisation (CDMO) and ribonucleic acid (RNA) technology provider, has announced the receipt of …

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026
Research and Development BMS, Scottish Medicines Consortium, colorectal cancer, oncology

Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the …

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026
AstronauTx, chair of the board

AstronauTx has announced the appointment of Adam Rosenberg as Chair of its Board of Directors. Rosenberg’s leadership experience includes holding …

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026
Research and Development Astellas Pharma, Scottish Medicines Consortium, Vyloy, gastric cancer, oncology

Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with …

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026
Angelini Pharma, CEO

Angelini Pharma, a branch of Angelini Industries, has announced the appointment of Sergio Marullo di Condojanni as CEO. Marullo di …

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026
Research and Development Oncology, QV Bioelectronics, glioblastoma

QV Bioelectronics, a medtech business specialising in implants for cancer treatment, has announced that it has received £4.5m in funding …

Alvotech appoints Lisa Graver as CEO

February 3, 2026
Alvotech, CEO

Alvotech has announced the appointment of Lisa Graver as CEO, following the retirement of Róbert Wessman. Wessman served as Chairman …

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026
Research and Development HonorHealth Research Institute, Neurology, ischemic stroke

HonorHealth Research Institute, a research institution collaborating with a wide range of experts to produce new treatments and devices, has …

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026
Accord healthcare, Associate Vice President, Country Head

Accord Healthcare has announced the appointment of Paul Burden as Associate Vice President and Country Head of Accord UK. Burden …

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026
Medical Communications United Nations, WHO, healthcare access, mental health, noncommunicable diseases, primary care

The 80th United Nations General Assembly (UNGA) has adopted the political declaration to combat mental health challenges and noncommunicable diseases …

The Gateway to Local Adoption Series

Latest content